Skip to main content

22NW, LP

SEC CIK
0001694297
Latest filing
Aug 14, 2026

Holdings in Q1 2026

Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.

Institution overview
Positions
16
−4 vs. Q4 2025
Portfolio value
$127.0M
−$2.75M (−2.1%) vs. Q4 2025
Filed
May 15, 2026
SEC
Holdings of 22NW, LP in Q1 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
FSTRFoster L B CoCOM1,067,186$29.8M23.4%−123,860−10.4%ReducedHistory
NKTRNektar TherapeuticsCOM NEW281,115$20.2M15.9%−50,000−15.1%ReducedHistory
NSPInsperity, Inc.COM493,000$13.3M10.5%+396,700+411.9%AddedHistory
MLYSMineralys Therapeutics, Inc.COM444,325$12.0M9.5%+86,000+24.0%AddedHistory
SRIStoneridge IncCOM2,466,975$11.9M9.4%+274,211+12.5%AddedHistory
FOXFFox Factory Holding CorpCOM678,165$11.2M8.8%+678,165NewHistory
CULPCulp IncCOM1,859,061$5.09M4.0%00.0%UnchangedHistory
CMTCore Molding Technologies IncCOM222,738$4.99M3.9%00.0%UnchangedHistory
RGNXREGENXBIO Inc.COM492,759$4.13M3.3%−430,920−46.7%ReducedHistory
UFIUnifi IncCOM NEW852,455$3.04M2.4%00.0%UnchangedHistory
TISITeam IncCOM NEW170,187$2.71M2.1%00.0%UnchangedHistory
RZLTRezolute, Inc.COM NEW820,653$2.50M2.0%00.0%UnchangedHistory
FARMFarmer Brothers CoCOM1,955,526$2.48M2.0%00.0%UnchangedHistory
ELDNEledon Pharmaceuticals, Inc.COM636,364$1.96M1.5%00.0%UnchangedHistory
PFXPhenixFIN CorpCOM43,115$1.68M1.3%−74,770−63.4%ReducedHistory
LFCRLifecore Biomedical, Inc.COM1,254––00.0%UnchangedHistory

Sold out since Q4 2025 (5)

Positions held at the end of Q4 2025 that are gone from this filing.

Positions of 22NW, LP sold out since Q4 2025
SecurityClassShares in Q4 2025Value in Q4 2025% of portfolio in Q4 2025History
MECMayville Engineering Company, Inc.COM414,280$7.76M6.0%History
MGTXMeiraGTx Holdings plcCOM586,519$4.66M3.6%History
SSKNSTRATA Skin Sciences, Inc.COM536,995$676.6K0.5%History
PMDPsychemedics CorpCOM276,034$441.7K0.3%History
ANEBAnebulo Pharmaceuticals, Inc.COM15,467,300––History